Cargando…
Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3
Phosphatase of Regenerating Liver-3 (PRL-3) is associated with cancer progression and metastasis. The mechanisms that drive PRL-3’s oncogenic functions are not well understood, partly due to a lack of research tools available to study this protein. We have begun to address these issues by developing...
Autores principales: | Smith, Caroline N., Kihn, Kyle, Williamson, Zachary A., Chow, K. Martin, Hersh, Louis B., Korotkov, Konstantin V., Deredge, Daniel, Blackburn, Jessica S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204944/ https://www.ncbi.nlm.nih.gov/pubmed/37220097 http://dx.doi.org/10.1371/journal.pone.0285964 |
Ejemplares similares
-
PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3
por: Zhang, Huizhi, et al.
Publicado: (2017) -
Erratum: PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3
por: Zhang, Huizhi, et al.
Publicado: (2017) -
A FRET-based screening method to detect potential inhibitors of the binding of CNNM3 to PRL2
por: Cai, Faji, et al.
Publicado: (2020) -
Phosphatase and Pseudo-Phosphatase Functions of Phosphatase
of Regenerating Liver 3 (PRL-3) Are Insensitive to Divalent Metals
In Vitro
por: Jolly, Jeffery T., et al.
Publicado: (2023) -
Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity
por: Gehring, Kalle, et al.
Publicado: (2020)